Aldesleukin Unknown Status Phase 2 Trials for Lung Cancers Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00003090Biological Therapy in Previously Treated Patients With Non-small Cell Lung Cancer